- Accueil >
- Publications >
- Efficacy and tolerance of everolimus in 123 consecutive advanced ER positive, HER2 negative breast cancer patients. A two center retrospective study
Efficacy and tolerance of everolimus in 123 consecutive advanced ER positive, HER2 negative breast cancer patients. A two center retrospective study
Auteurs
D. Chocteau-Bouju, C. Chakiba, L. Mignot, N. Madranges, J.-Y. Pierga, P. Beuzeboc, N. Quenel-Tueux, V. Dieras, H. Bonnefoi, M. Debled, P. Cottu